SMD Rise PCL

SMD Rise PCL Debt/Market Cap

The Debt to Market Capitalization Ratio of SMD Rise PCL (SMD100.BK) as of Oct 19, 2026 is 72.96 %. In the previous year, Debt to Market Capitalization Ratio was 10.71 % — a change of 581.00% (higher).

Debt/Market Cap

72.96 %

YoY

581.00%

Last updated:

Debt to Market Capitalization Ratio of SMD Rise PCL is 2025 72.96 % . Debt to Market Capitalization Ratio of SMD Rise PCL was 2024 10.71 % . It decreases by 581.00% higher compared to the previous year.

The SMD Rise PCL Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2017
41.26 THB
Jan 1, 2018
49.31 THB
Jan 1, 2019
29.51 THB
Jan 1, 2020
64.30 THB
Jan 1, 2021
62.78 THB
Jan 1, 2022
11.82 THB
Jan 1, 2023
10.71 THB
Jan 1, 2025
72.96 THB
The SMD Rise PCL Debt/Market Cap history
YEARDebt/Market CapYoY
72.96 %+581.00%
10.71 %-9.34%
11.82 %-81.18%
62.78 %-2.36%
64.30 %+117.91%
29.51 %-40.15%
49.31 %+19.50%
41.26 %-19.32%
51.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SMD Rise PCL Stock analysis

What does SMD Rise PCL do? SMD Rise PCL, listed on the Stock Exchange of Thailand with ticker SMD100.BK and ISIN THA320A10Y01, operates in the Health Care sector. The company was founded through an IPO on June 17, 2021. SMD Rise PCL is engaged in the distribution of medical devices and equipment, focusing on the import and distribution of medical supplies and services for medical equipment. The company specializes in respiratory system-related medical equipment, particularly offering sleep monitoring services and counseling on the use of positive pressure air compressors (CPAP) for treating obstructive sleep apnea (OSA). Its services target patients with sleep disorders, including snoring, obstructive sleep apnea, insomnia, and other conditions such as excessive daytime sleepiness, sleepwalking, bruxism, and leg twitching. Additionally, the company provides support for patients with high blood pressure, diabetes, and obesity. SMD Rise PCL's subsidiary is Saint Medical Trading Co., Ltd. The company's website is https://www.saintmed.com/. SMD Rise PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SMD Rise PCL stock

Debt to Market Capitalization Ratio of SMD Rise PCL is 72.96 % in 2025.

Debt to Market Capitalization Ratio of SMD Rise PCL changed from 10.71 % to 72.96 %, representing a 581.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio SMD Rise PCL since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's SMD Rise PCL with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — SMD Rise PCL

All Key Metrics — SMD Rise PCL